Human Albumin 20% IV infusion

Marketed by Dexa Medica

Ingredients in every 50 ml

Human Albumin 10000 mg

Each package contains

1 bottle of 50 ml

Other details

Dosage form:Intravenous infusion
Flavour: None

W.H.O. classification

ATC Level 1: B - Blood and blood forming organs
ATC Level 2: B05 - Blood Substitutes and Perfusion Solutions
ATC Level 3: B05A - Blood and Related Products

Warnings

Pregnancy

SAFE IF PRESCRIBEDThis item is safe for use during pregnancy.

Lactation

SAFE IF PRESCRIBEDThis item is safe for use during lactation.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Available in

Indonesia

Dosage information

FOR ALL AGES
Human albumin can be administered by the intravenous route,
either undiluted or after dilution in an isotonic solution
(e.g. 5 % glucose or 0.9 % sodium chloride).
Albumin solutions must not be diluted with water for
injections as this may cause haemolysis in recipients.
The infusion rate should be adjusted according to the
individual circumstances and the indication.
In plasma exchange the infusion-rate should be adjusted to
the rate of removal.
If large volumes are administered, the product should be
warmed to room or body temperature before use.
Do not use solutions which are cloudy or contain residues
(deposits/particles). This may indicate that the protein is
unstable or that the solution has become contaminated

OTHER DETAILS
The dose required depends on the size of the patient, the severity of trauma or illness and on continuing fluid and protein losses. Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required.
If human albumin is to be administered, haemodynamic performance should be monitored regularly; this may include:
– arterial blood pressure and pulse rate
– central venous pressure
– pulmonary artery wedge pressure
– urine output
– electrolyte
– haematocrit/haemoglobin.

Indication

Increase in oncotic pressure in case of oncotic deficiency. Diluted as a 4-5% solution for iso-oncotic volume replacement with long-term effect. Therapy of albumin deficiency.

Disclaimer

The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.